Radio 94.5 KMYT

The FDA has cleared Merck’s Lipfendra, the first oral PCSK9 inhibitor, which lowered LDL cholesterol by nearly 60% in trials.

FDA Approves New Once-Daily Drug That Drastically Lowers Cholesterol Levels | Radio 94.5

A new Alzheimer’s drug, diranersen, slowed cognitive decline by reducing tau protein levels in early-stage patients, offering a different approach than current amyloid-focused treatments.